Practice question

Answer the question and get instant feedback.

MediumGuidelines support FDA-approved anti-obesity medications (e.g. GLP-1 RA) for BMI ≥30 or ≥27 with comorbidityObesityaga clinical practice guideline (2022): pharmacological management of obesity

A 52-year-old with obesity (BMI 37 kg/m²) and OSA has tried lifestyle therapy. Which pharmacologic strategy is guideline-supported to assist weight loss and metabolic health?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.